The price of Vor Biopharma Inc (NASDAQ:VOR) shares last traded on Wall Street rose 52.83% to $1.62.
VOR stock price is now 306.11% away from the 50-day moving average and 96.54% away from the 200-day moving average. The market capitalization of the company currently stands at $202.43M.
With the price target maintained at $3, H.C. Wainwright recently Upgraded its rating from Neutral to Buy for Vor Biopharma Inc (NASDAQ: VOR). On July 26, 2022, Wedbush recently initiated its ‘Outperform’ rating on the stock quoting a target price of $18, while ‘Goldman’ rates the stock as ‘Neutral’
In other news, ROBERT ANG, Officer bought 40,627 shares of the company’s stock on Jun 30 ’25. The stock was bought for $70,289 at an average price of $1.73. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 13 ’25, CHIEF MEDICAL OFFICER Attar Eyal C. sold 2,227 shares of the business’s stock. A total of $3,162 was realized by selling the stock at an average price of $1.42. This leaves the insider owning 126,625 shares of the company worth $0.21 million. A total of 38.49% of the company’s stock is owned by insiders.
During the past 12 months, Vor Biopharma Inc has had a low of $0.13 and a high of $1.80. As of last week, the company has a debt-to-equity ratio of 0.47, a current ratio of 3.88, and a quick ratio of 3.88. The fifty day moving average price for VOR is $0.39898 and a two-hundred day moving average price translates $0.82431 for the stock.
The latest earnings results from Vor Biopharma Inc (NASDAQ: VOR) was released for 2025-03-31.
